QTREX QUANTUM LTD

QTREX Quantum Ltd. amends its F‑1, expanding to 1.8 M shares and redirecting proceeds to R&D of respiratory‑support tech, positioning itself as a non‑invasive ventilation alternative.

QTREX QUANTUM LTD’s Nasdaq journey: volatile stock, deep R&D in non‑invasive respiratory tech, and a push toward profitability amid rising healthcare demand.

QTREX’s new cryogenic chip carrier, built with its single‑build additive‑manufactured electronics platform, cuts connectorization, boosts routing density, and enhances thermal shielding—transforming quantum processor interfaces for next‑generation c…